The Centers for Medicare & Medicaid Services (CMS) recently published its Proposed 2026 Physician Fee Schedule Rule (Proposed Rule), with extensive implications for drug pricing, Average Sales Price (ASP) calculations, and...more
8/14/2025
/ Centers for Medicare & Medicaid Services (CMS) ,
Compliance ,
Drug Pricing ,
Fair Market Value ,
False Claims Act (FCA) ,
Manufacturers ,
Medicaid ,
Medicare ,
Pharmaceutical Industry ,
Proposed Rules ,
Regulatory Requirements ,
Reporting Requirements
On July 31, the U.S. Department of Justice (DOJ) announced a settlement in United States ex rel. Lenore v. Illumina, Inc, the first case in which underlying cybersecurity issues formed the basis of a settlement under the...more
8/8/2025
/ Cybersecurity ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Department of Veterans Affairs ,
Enforcement Actions ,
False Claims Act (FCA) ,
Food and Drug Administration (FDA) ,
Healthcare Fraud ,
Life Sciences ,
Medical Devices ,
NASA ,
Regulatory Requirements ,
Risk Management ,
Settlement ,
Whistleblowers